2019 International Congress Archives - Page 67 of 217

2019 International Congress

September 22-26, 2019. Nice, France.

Dorsolateral striatal neuronal activity in a rat model of Parkinson`s disease with levodopa-induced dyskinesias

X. Jin, D. Milakara, K. Schwabe, J. Krauss, M. Alam (Nanjing, China)
Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)
Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)
Drug-induced dystonia

JB. Paredes, V. Hristova, J. Poles, S. Madrona, P. Torre, I. Moreno, S. Argos, A. Canovas, JC. Castrillo, JL. Moreno (Madrid, Spain)
Drug-induced Negative Myoclonus: A Case Report

L. Lerjefors, M. Mainardi, A. Antonini, M. Carecchio (Padova, Italy)
Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents

J. Randhawa, R. Mehanna (Houston, TX, USA)
Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

I. Csoti, N. Koleva-Alazeh (Leun, Germany)
Dual-task in Parkinson’s disease: a gait analysis and functional MRI study

E. Sarasso, A. Gardoni, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi, F. Agosta (Milan, Italy)
Duloxetine for pain in Parkinsons disease; A single center double blind randomised placebo controlled trial.

S. Azmin, T. Canento, B. Cruse, S. Sung, M. Farrell, A. Evans (Kuala Lumpur, Malaysia)
Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea

S. Isaacson, M. Lew, F. Pagan, R. Pahwa, D. Chary, T. Clinch (Boca Raton, FL, USA)